Browsing by Author Rojo, Federico
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
|---|---|---|
| 10-Jun-2021 | Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario | Nadal, Ernest; Bautista, Dolores; Cabezón Gutiérrez, Luis; Ortega, Ana Laura; Torres, Héctor; Carcedo, David; Ruiz de Alda, Lucía; Garcia, J. Francisco; Vieitez, Paula; Rojo, Federico |
| 19-Mar-2022 | Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain | Rojo, Federico; Conde, Esther; Torres, Héctor; Cabezón Gutiérrez, Luis; Bautista, Dolores; Ramos, Inmaculada; Carcedo, David; Arrabal, Natalia; García, J. Francisco; Galán, Raquel; Nadal, Ernest |
| 5-Apr-2016 | FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth | Slebe, Felipe; Rojo, Federico; Vinaixa Crevillent, Maria; García Rocha, Mar; Testoni, Giorgia; Guiu, Marc; Planet, Evarist; Samino Gené, Sara; Arenas, Enrique J.; Beltran, Antoni; Rovira, Ana; Lluch Hernández, Ana; Salvatella i Giralt, Xavier; Yanes, Oscar; Albanell Mestres, Joan; Guinovart, Joan J. (Joan Josep), 1947-; Gomis i Cabré, Roger |
| 28-Mar-2017 | Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer | Fernández Martínez, Aranzazu; Pascual, Tomás; Perrone, Giuseppe; Morales, Serafín; Haba, Juan de la; González Rivera, Milagros; Galván, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucía; Prats de Puig, Miquel; Rojo, Federico; Manso, Luis; Paré, Laia; Alonso, Immaculada; Albanell Mestres, Joan; Vivancos, Ana; González, Antonio; Matito, Judit; González, Sonia; Fernández Ruiz, Pedro Luis; Adamo, Barbara; Muñoz Mateu, Montserrat; Viladot, Margarita; Font, Carme; Aya, Francisco; Vidal Losada, Maria Jesús; Caballero, Rosalía; Carrasco, Eva; Altomare, Vittorio; Tonini, Giuseppe; Prat Aparicio, Aleix; Martín, Miguel |
| 27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertran, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
| 20-May-2022 | Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer | Adam Artigues, Anna; Arenas Lahuerta, Enrique Javier; Martínez Sabadell, Alex; Brasó Maristany, Fara; Cervera, Raimundo; Tormo, Eduardo; Hernando, Cristina; Martínez, Maria Teresa; Carbonell Asins, Juan; Simón, Soraya; Poveda, Jesús; Moragón, Santiago; Zazo, Sandra; Martínez, Débora; Rovira, Ana; Burgues, Octavio; Rojo, Federico; Albanell Mestres, Joan; Bermejo, Begoña; Lluch Hernández, Ana; Prat Aparicio, Aleix; Arribas, Joaquín; Eroles, Pilar; Cejalvo, Juan Miguel |
| 27-Jan-2022 | Update on management recommendations for advanced cutaneous squamous cell carcinoma | Garcia-Foncillas, Jesús; Tejera Vaquerizo, Antonio; Sanmartín, Onofre; Rojo, Federico; Mestre, Javier; Martín, Salvador; Azinovic, Ignacio; Mesía Nin, Ricard |